Glaucoma Drainage Device Erosions in Patients Receiving Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy.
Yasmin Florence Khodeja IslamElizabeth A VannerArindel S R MaharajStephen G SchwartzKrishna KishorPublished in: Clinical ophthalmology (Auckland, N.Z.) (2022)
In patients with diabetic retinopathy, the use of anti-VEGF does not result in an increased rate of GDD erosions or recurrent erosions. Further research is needed over a longer follow-up period to determine if longer or more frequent anti-VEGF treatment is a risk factor for recurrent erosions.